Cargando…

Allelic imbalance in 1p, 7q, 9p, 11p, 12q and 16q regions in non-small cell lung carcinoma and its clinical association: a pilot study

In lung cancer pathogenesis, genetic instability, i.e., loss of heterozygosity (LOH) and microsatellite instability (MSI) is a frequent molecular event, occurring at an early stage of cancerogenesis. The presence of LOH/MSI in non-small cell lung carcinoma (NSCLC) was found in many chromosomal regio...

Descripción completa

Detalles Bibliográficos
Autores principales: Czarnecka, Karolina H., Migdalska-Sęk, Monika, Antczak, Adam, Pastuszak-Lewandoska, Dorota, Kordiak, Jacek, Nawrot, Ewa, Domańska, Daria, Kaleta, Dorota, Górski, Paweł, Brzeziańska, Ewa Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835956/
https://www.ncbi.nlm.nih.gov/pubmed/24091944
http://dx.doi.org/10.1007/s11033-013-2782-1
_version_ 1782292243228393472
author Czarnecka, Karolina H.
Migdalska-Sęk, Monika
Antczak, Adam
Pastuszak-Lewandoska, Dorota
Kordiak, Jacek
Nawrot, Ewa
Domańska, Daria
Kaleta, Dorota
Górski, Paweł
Brzeziańska, Ewa Barbara
author_facet Czarnecka, Karolina H.
Migdalska-Sęk, Monika
Antczak, Adam
Pastuszak-Lewandoska, Dorota
Kordiak, Jacek
Nawrot, Ewa
Domańska, Daria
Kaleta, Dorota
Górski, Paweł
Brzeziańska, Ewa Barbara
author_sort Czarnecka, Karolina H.
collection PubMed
description In lung cancer pathogenesis, genetic instability, i.e., loss of heterozygosity (LOH) and microsatellite instability (MSI) is a frequent molecular event, occurring at an early stage of cancerogenesis. The presence of LOH/MSI in non-small cell lung carcinoma (NSCLC) was found in many chromosomal regions, but exclusive of 3p their diagnostic value remains controversial. In this study we focused on other than 3p regions—1p31.2, 7q32.2, 9p21.3, 11p15.5, 12q23.2 and 16q22—the loci of many oncogenes and tumour suppressor genes. To analyze the potential role of LOH/MSI involved in NSCLC pathogenesis we allelotyped a panel of 13 microsatellite markers in a group of 56 cancer specimens. Our data demonstrate the presence of allelic loss for all (13) analyzed markers. Total LOH/MSI frequency in NSCLC was the highest for chromosomal region 11p15.5 (25.84 %), followed by 9p21.3 and 1p31.2 (19.87 and 16.67 % respectively). A statistically significant increase of total LOH/MSI frequency was detected for the 11p15.5 region (p = 0.0301; χ(2) test). The associations of total LOH/MSI frequency: 1) increase in 11p15.5 region (p = 0.047; χ(2) test) and 2) decrease in 7q32.2 region (p = 0.037; χ(2) test) have been statistically significant in AJCC III (American Joint Committee on Cancer Staging). In Fractional Allele Loss (FAL) index analysis, the correlation with cigarette addiction has been statistically significant. The increased amount of cigarettes smoked (pack years) in a lifetime correlates with increasing FAL (p = 0.024; Kruskal–Wallis test). These results demonstrate that LOH/MSI alternation in studied chromosomal regions is strongly influenced by tobacco smoking but do not seem to be pivotal NSCLC diagnostic marker with prognostic impact.
format Online
Article
Text
id pubmed-3835956
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-38359562013-11-22 Allelic imbalance in 1p, 7q, 9p, 11p, 12q and 16q regions in non-small cell lung carcinoma and its clinical association: a pilot study Czarnecka, Karolina H. Migdalska-Sęk, Monika Antczak, Adam Pastuszak-Lewandoska, Dorota Kordiak, Jacek Nawrot, Ewa Domańska, Daria Kaleta, Dorota Górski, Paweł Brzeziańska, Ewa Barbara Mol Biol Rep Article In lung cancer pathogenesis, genetic instability, i.e., loss of heterozygosity (LOH) and microsatellite instability (MSI) is a frequent molecular event, occurring at an early stage of cancerogenesis. The presence of LOH/MSI in non-small cell lung carcinoma (NSCLC) was found in many chromosomal regions, but exclusive of 3p their diagnostic value remains controversial. In this study we focused on other than 3p regions—1p31.2, 7q32.2, 9p21.3, 11p15.5, 12q23.2 and 16q22—the loci of many oncogenes and tumour suppressor genes. To analyze the potential role of LOH/MSI involved in NSCLC pathogenesis we allelotyped a panel of 13 microsatellite markers in a group of 56 cancer specimens. Our data demonstrate the presence of allelic loss for all (13) analyzed markers. Total LOH/MSI frequency in NSCLC was the highest for chromosomal region 11p15.5 (25.84 %), followed by 9p21.3 and 1p31.2 (19.87 and 16.67 % respectively). A statistically significant increase of total LOH/MSI frequency was detected for the 11p15.5 region (p = 0.0301; χ(2) test). The associations of total LOH/MSI frequency: 1) increase in 11p15.5 region (p = 0.047; χ(2) test) and 2) decrease in 7q32.2 region (p = 0.037; χ(2) test) have been statistically significant in AJCC III (American Joint Committee on Cancer Staging). In Fractional Allele Loss (FAL) index analysis, the correlation with cigarette addiction has been statistically significant. The increased amount of cigarettes smoked (pack years) in a lifetime correlates with increasing FAL (p = 0.024; Kruskal–Wallis test). These results demonstrate that LOH/MSI alternation in studied chromosomal regions is strongly influenced by tobacco smoking but do not seem to be pivotal NSCLC diagnostic marker with prognostic impact. Springer Netherlands 2013-10-04 2013 /pmc/articles/PMC3835956/ /pubmed/24091944 http://dx.doi.org/10.1007/s11033-013-2782-1 Text en © The Author(s) 2013 https://creativecommons.org/licenses/by/2.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Article
Czarnecka, Karolina H.
Migdalska-Sęk, Monika
Antczak, Adam
Pastuszak-Lewandoska, Dorota
Kordiak, Jacek
Nawrot, Ewa
Domańska, Daria
Kaleta, Dorota
Górski, Paweł
Brzeziańska, Ewa Barbara
Allelic imbalance in 1p, 7q, 9p, 11p, 12q and 16q regions in non-small cell lung carcinoma and its clinical association: a pilot study
title Allelic imbalance in 1p, 7q, 9p, 11p, 12q and 16q regions in non-small cell lung carcinoma and its clinical association: a pilot study
title_full Allelic imbalance in 1p, 7q, 9p, 11p, 12q and 16q regions in non-small cell lung carcinoma and its clinical association: a pilot study
title_fullStr Allelic imbalance in 1p, 7q, 9p, 11p, 12q and 16q regions in non-small cell lung carcinoma and its clinical association: a pilot study
title_full_unstemmed Allelic imbalance in 1p, 7q, 9p, 11p, 12q and 16q regions in non-small cell lung carcinoma and its clinical association: a pilot study
title_short Allelic imbalance in 1p, 7q, 9p, 11p, 12q and 16q regions in non-small cell lung carcinoma and its clinical association: a pilot study
title_sort allelic imbalance in 1p, 7q, 9p, 11p, 12q and 16q regions in non-small cell lung carcinoma and its clinical association: a pilot study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835956/
https://www.ncbi.nlm.nih.gov/pubmed/24091944
http://dx.doi.org/10.1007/s11033-013-2782-1
work_keys_str_mv AT czarneckakarolinah allelicimbalancein1p7q9p11p12qand16qregionsinnonsmallcelllungcarcinomaanditsclinicalassociationapilotstudy
AT migdalskasekmonika allelicimbalancein1p7q9p11p12qand16qregionsinnonsmallcelllungcarcinomaanditsclinicalassociationapilotstudy
AT antczakadam allelicimbalancein1p7q9p11p12qand16qregionsinnonsmallcelllungcarcinomaanditsclinicalassociationapilotstudy
AT pastuszaklewandoskadorota allelicimbalancein1p7q9p11p12qand16qregionsinnonsmallcelllungcarcinomaanditsclinicalassociationapilotstudy
AT kordiakjacek allelicimbalancein1p7q9p11p12qand16qregionsinnonsmallcelllungcarcinomaanditsclinicalassociationapilotstudy
AT nawrotewa allelicimbalancein1p7q9p11p12qand16qregionsinnonsmallcelllungcarcinomaanditsclinicalassociationapilotstudy
AT domanskadaria allelicimbalancein1p7q9p11p12qand16qregionsinnonsmallcelllungcarcinomaanditsclinicalassociationapilotstudy
AT kaletadorota allelicimbalancein1p7q9p11p12qand16qregionsinnonsmallcelllungcarcinomaanditsclinicalassociationapilotstudy
AT gorskipaweł allelicimbalancein1p7q9p11p12qand16qregionsinnonsmallcelllungcarcinomaanditsclinicalassociationapilotstudy
AT brzezianskaewabarbara allelicimbalancein1p7q9p11p12qand16qregionsinnonsmallcelllungcarcinomaanditsclinicalassociationapilotstudy